Anticardiolipin Antibodies in Behçet's Syndrome: a Predictor of a More Severe Disease

Overview

Journal Clin Rheumatol

Publisher Springer

Specialty Rheumatology

Date 1989 Jun 1

PMID 2758775

Citations 4

Authors

R M Pereira

C R Goncalves

C Bueno

E de S Meirelles

W Cossermelli

R M de Oliveira

Affiliations

Soon will be listed here.

Abstract

A high incidence of anticardiolipin antibodies were detected in 7 of 20 patients (35%) with Behçet's Syndrome. Three patients had IgG-ab, three had IgM-ab and one had both IgG and IgM antibodies. IgG-ACA was detected mainly in patients with ocular disease (30%) and one of them also has cerebral vascular disease. A lower incidence of ACA was found in the patients taking steroids compared with the ones taking other drugs. This work draws attention to the more severe disease present in patients with ACA and also the possibility of such tests become negative in patients taking immunosuppressive drugs.

Citing Articles

Auto-immunity profile evaluation during different clinical manifestations of Behçet disease in Algerian patients: effect of corticosteroid treatment.

Djaballah-Ider F, Djaballah A, Djeraba Z, Chaib S, Touil-Boukoffa C Inflammopharmacology. 2019; 27(6):1113-1122.

PMID: 30721371 DOI: 10.1007/s10787-019-00567-8.

Behçet's Disease as a Model of Venous Thrombosis.

La Regina M, Gasparyan A, Orlandini F, Prisco D Open Cardiovasc Med J. 2010; 4:71-7.

PMID: 20360979 PMC: 2847254. DOI: 10.2174/1874192401004020071.

Anticardiolipin (aCL) antibodies in a patient with Behçet's syndrome with vena cava inferior thrombosis.

Ebo D, Bracke P, De Clerck L, Francx L, Stevens W Clin Rheumatol. 1997; 16(1):96-8.

PMID: 9132335 DOI: 10.1007/BF02238771.

Absence of antiphospholipid antibodies in Behçet's disease.

Karmochkine M, Boffa M, Wechsler B, Piette J, Godeau P Ann Rheum Dis. 1993; 52(8):623.

PMID: 8215632 PMC: 1005127. DOI: 10.1136/ard.52.8.623-a.

References

Hull R, Harris E, Gharavi A, Tincani A, Asherson R, Valesini G . Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis. 1984; 43(5):746-8. PMC: 1001520. DOI: 10.1136/ard.43.5.746. View

Hamza M, Meyer O . [Anticardiolipin antibodies in Behçet's disease]. Presse Med. 1986; 15(27):1281. View

Boey M, Colaco C, Gharavi A, Elkon K, Loizou S, Hughes G . Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br Med J (Clin Res Ed). 1983; 287(6398):1021-3. PMC: 1549560. DOI: 10.1136/bmj.287.6398.1021. View

Chamberlain M . Behcet's syndrome in 32 patients in Yorkshire. Ann Rheum Dis. 1977; 36(6):491-99. PMC: 1000153. DOI: 10.1136/ard.36.6.491. View

Lockshin M, Druzin M, Goei S, Qamar T, Magid M, Jovanovic L . Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med. 1985; 313(3):152-6. DOI: 10.1056/NEJM198507183130304. View